Position in DXCM
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$3,075,066
+$133,891 QoQ
Shares Held
45,658
-2.5% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#17
of 115 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 40.27771693898112.ToString("F0")%
Shared 0.ToString("F0")%
None 59.72228306101888.ToString("F0")%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026YOUSIF CAPITAL MANAGEMENT, LLC holds $101,151,140 across 30 Medical Devices names. DXCM ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
222,256 | $20,167,509 | |
| 2 | MDT |
Medtronic plc
|
251,659 | $19,687,283 | |
| 3 | SYK |
Stryker Corp
|
47,697 | $15,016,923 | |
| 4 | BSX |
Boston Scientific Corp
|
194,582 | $8,304,759 | |
| 5 | EW |
Edwards Lifesciences Corp
|
75,700 | $6,847,822 | |
| 6 | PEN |
Penumbra Inc
|
11,248 | $3,551,556 | |
| 7 | DXCM |
Dexcom Inc
This page
|
45,658 | $3,075,066 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
46,824 | $2,997,204 |
All Filings in DXCM
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,075,066 | 45,658 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,941,175 | 46,834 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,212,374 | 48,401 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $3,350,032 | 49,785 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $4,663,817 | 53,429 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $3,615,614 | 52,945 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $4,238,076 | 54,495 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $3,866,733 | 57,678 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $6,549,962 | 57,770 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $8,000,493 | 57,682 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $7,330,120 | 59,071 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $6,238,971 | 66,870 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $8,733,282 | 67,958 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $7,667,415 | 65,996 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $7,505,433 | 66,279 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $6,300,644 | 78,230 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $5,931,842 | 79,590 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,462,970 | 19,257 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,536,014 | 18,892 | Shares | Sole | 2022-01-31 | |
| No filing history on record for this holder in this stock. | ||||||